50 ml tirzepatide New clinical trial: Zepbound (tirzepatide) helped adults lose an average of 20.2% of their body weight—around lbs—over 72 weeks, outperforming Wegovy's 13.7% (~33 lbs). Credit to: https://www.healthline.com/health-news/zepbound-wegovy-weight-loss Zepbound users: Side effects when

Improved Recovery: Speed up your post-workout recovery by reducing muscle soreness and fatigue, ensuring you're ready for your next training session

These factors can affect the pharmacokinetics and pharmacodynamics of GLP-1Ras (1)

GLP-1 receptor agonists have changed that, particularly for patients with obesity

For many, the health benefits of weight reduction and resolving dangerous comorbidities such as sleep apnea and diabetes make it worthwhile to try a GLP-1, despite the possible risks

However, some people may experience mild side effects such as stomach upset, diarrhoea, and allergic reactions

If you are considering combining these medications, this is absolutely a conversation to have with your prescribing physician